172 related articles for article (PubMed ID: 36039456)
1. Analyses of Ocular Adverse Reactions Associated With Anticancer Drugs Based on the Japanese Pharmacovigilance Database.
Tanaka J; Koseki T; Kondo M; Ito Y; Yamada S
Anticancer Res; 2022 Sep; 42(9):4439-4451. PubMed ID: 36039456
[TBL] [Abstract][Full Text] [Related]
2. Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
Sato K; Mano T; Iwata A; Toda T
J Alzheimers Dis; 2021; 82(3):1333-1344. PubMed ID: 34151816
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M
Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094
[TBL] [Abstract][Full Text] [Related]
4. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
Nagai J; Ishikawa Y
PLoS One; 2021; 16(12):e0260980. PubMed ID: 34855908
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database.
Uchida M; Kondo Y; Suzuki S; Hosohata K
Ann Pharmacother; 2019 Dec; 53(12):1200-1206. PubMed ID: 31347378
[No Abstract] [Full Text] [Related]
6. Occurrence of voriconazole-induced cutaneous squamous cell carcinoma in Japan: data mining from different national pharmacovigilance databases.
Tanaka H; Okuma M; Ishii T
Pharmazie; 2022 Oct; 77(10):307-310. PubMed ID: 36273254
[TBL] [Abstract][Full Text] [Related]
7. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
8. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K
Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database.
Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N
BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
11. Quality evaluation of the Japanese Adverse Drug Event Report database (JADER).
Tsuchiya M; Obara T; Sakai T; Nomura K; Takamura C; Mano N
Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):173-181. PubMed ID: 31823506
[TBL] [Abstract][Full Text] [Related]
12. Analysis of drug-induced hand-foot syndrome using a spontaneous reporting system database.
Yoshida Y; Sasaoka S; Tanaka M; Matsumoto K; Inoue M; Satake R; Shimada K; Mukai R; Suzuki T; Iwata M; Goto F; Mori T; Mori K; Yoshimura T; Nakamura M
Ther Adv Drug Saf; 2022; 13():20420986221101963. PubMed ID: 35646307
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Appendicitis Cases in the Japanese Adverse Drug Event Report (JADER) Database.
Kyotani Y; Zhao J; Nakahira K; Yoshizumi M
Biol Pharm Bull; 2023; 46(5):655-660. PubMed ID: 37121692
[TBL] [Abstract][Full Text] [Related]
14. A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis.
Fujiwara M; Kawasaki Y; Yamada H
PLoS One; 2016; 11(4):e0154425. PubMed ID: 27119382
[TBL] [Abstract][Full Text] [Related]
15. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
[TBL] [Abstract][Full Text] [Related]
16. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.
Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K
Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database.
Sato J; Eren T; Murata S; Shimizu T; Uchida M
Anticancer Res; 2022 Dec; 42(12):5917-5925. PubMed ID: 36456140
[TBL] [Abstract][Full Text] [Related]
18. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
20. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
Sato K; Mano T; Iwata A; Toda T
J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
